ArticleFrontiers in cardiovascular medicine2026
Empagliflozin attenuates elaidic acid-exacerbated cardiac dysfunction post-myocardial infarction via suppression of the NF-κB/NLRP3 pathway.
Qingkai Yan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.